baber/WOPTO huggingface dataset:
Patent MX-3152-E (MX)
Title: Procedimiento de preparacion de derivados de  8 - un procedimiento mejorado para la obtencion selectamino - teo filina                                iva de una  poli alquilen poli amina  predominantemente no ciclica
Inventor: QUELET JEAN RAYMOND
IPC: C07D473/08
Filed: 1976-03-11
Abstract: La presente invención se refiere a un procedimientde preparación de derivados de 8-amino-teofilina de fórmula (VER FIGURA) en la cual A es un radical alcohileno lineal o ramificado que tiene de 2 a 4  la fórmula general (VER FIGURA) en donde R es un dical alcohileno lineal o ramificado que tiene de X es un número de 2 a 6, e y es un número de 2 a 6, con un compuesto alcanolamina de la fórmula (VER FIGURA) en donde R es un hidrógeno o un radical alquilo de bajo contenido; X es un número de 2 a 6; e y es un número de 0 a 3, en la presencia de una cantidad catalíticamente efectiva, de una substancia que contiene fósforo a temperaturas comprendidas entre 250°C y 350°C bajo una presión suficiente para mantener la mezcla esencialmente en la fase líquida y la recuperación del compuesto poliamina polialquileno, de una mezcla de reacción resultante, caracterizado porque la substancia que comprende fósforo es escogida de los fosfatos de metales acídicos compuestos de ácido fósforico y sus compuendensa una piperazina sustituída de fórmula (VER Fe fosfato, alquilo o arilo, ésteres de fosfato alqinen anteriormente, con un derivado de fórmula (VEo o arilo, y ácido fosfóricos, monosales de metal alcalino, de ácido fosfórico, los tioanálogos de lndose la reacción de condensación mediante fusión de los reactivos juntos, a una temperatura aproximadamente 180 a 190°C.
Patent MX-3303-E (MX)
Title: Mejoras en metodo para producir un cuerpo ceramico sinterizado y producto resultante
Inventor: COPPOLA JOHN ALLEN
IPC: C04B35/565
Filed: 1976-06-07
Abstract: La presente invención se refiere a un producto cerámico sinterizado, que resulta de las mejoras hechas a un método que sirve para producir un cuerpo cerámico sinterizado; dicho producto consta esencialmente de : a) del 91 al 99.35 por ciento por peso de carburo de silicio; b) del 0.5 al 5.0 por ciento de carbón no combinado; c) de 0.15 al 3.0 por ciento de boro y d) hasta el 1.0 por ciento de carbón adicional; y que tiene una densidad mínima de 2.40 g/cc; dicho producto se caracteriza en que el carburo de silicio contiene, cuando menos, alrededor del 5 por ciento por peso de alfa-carburo de silicio cristalino no cúbico.
Patent MX-5863-E (MX)
Inventor: KITA DONALD ALBERT
IPC: C07H7/02
Filed: 1979-07-19
Abstract: 2-Ketogluconate present in a mixture with 2-ketogulonate is destroyed by fermentation with a strain of Pseudomonas fluorescens leaving desired 2-ketogulonate intact. Subsequent hydrolysis of the 2-ketogulonate yields ascorbic acid. The preferred Pseudomonas strains are NRRL B10 and ATCC 13430.
Patent PT-1182000-E (PT)
Inventor: PETER CHAIKOWSKY
IPC: B23D45/04
Filed: 2000-08-24
Abstract: A miter saw (10) including a base assembly (11), a rotatable table (12) rotatably connected to the base assembly (11), a fence (20,21) connected to the base assembly (11), a saw assembly (30) including a motor (17) and a blade (14) driven by the motor (17), and a pivot arm (8) pivotally attached to the table and pivotally supporting the saw assembly (30) about a first axis (A) substantially parallel to the table plane (11P), allowing a user to plunge the blade (14) below the table plane (11P), wherein the distance (ABP) between the first axis (A) and the table plane (11P) is about 0.472 times the radius (R). Also, the distance (AFP) between the first axis (A) and the fence plane (20P) is about 1.45 times the radius (R), and the distance (ABC) between the first axis (A) and the blade center (BC) is about 1.882 times the radius (R). The distance (BCBP) between the blade center (BC) and the table plane (11P) is about 0.57 times the radius (R) when the blade (14) is plunged below the table plane (11P). <IMAGE>
Patent PT-1206867-E (PT)
Title: Transport format combination indicator mapping for telecommunications
Inventor: BERGSTROEM JOAKIM KARL OLOF
IPC: H04W88/14
Filed: 2000-08-25
Abstract: A Calculated Transport Format Combination (CTFC) provides efficient signalling of transport format combinations to be assigned TFCI values. A sequence of CTFCs is signalled from higher layers (30) to Node B (22) and the user equipment (UE) (20), where each CTFC in order is allocated a TFCI value. From the CTFC both Node B and the user equipment (UE) can determine the exact transport format combinations the TFCI values (used to communicate between Node B and UE) represent. The sequence of CTFC values includes only CTFC values for valid combinations of transport formats.
Patent PT-1237864-E (PT)
Inventor: PFLAUM ZLATKO
IPC: C07D207/34
Filed: 2000-12-05
Abstract: Atorvastatin, the substance known by the chemical name [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt, is readily available in one of its crystalline forms as it is known from the prior art. The present invention relates to a novel process for preparing atorvastatin in an amorphous form by precipitating the atorvastatin using a solvent of a second type from a solution of atorvastatin which is provided with a solvent of a first type. This process is useful for the conversion of atorvastatin in a crystalline form into atorvastatin in an amorphous form.
Patent PT-1224397-E (PT)
Title: Electric ventilator
Inventor: GOLD MATTHIAS
IPC: F04D29/54
Filed: 2001-08-29
Abstract: The invention relates to an electric fan, in particular, for motor vehicles, comprising an electric drive motor, a fan wheel coupled with the drive motor, and an electronic control unit for controlling the motor. In order to make the electric fan structurally more simple and more cost-effective to assemble, it is proposed that the drive motor and the control unit be arranged in a common housing, and that the housing have air vents for passage of a flow of cooling air generatable by the fan wheel, and a heat sink of the control unit be arranged at at least one air vent.
Patent PT-1293735-E (PT)
Title: Refrigerant circuit
Inventor: SUGIYAMA KUNIO
IPC: F25B13/00
Filed: 2002-09-10
Abstract: In a refrigerant circuit, an expansion valve 4 is connected to a heat exchanger 5 by a refrigerant pipe, and a bypass pipe 7/9 is provided. By way of a bypass pipe 9 having a check valve 10, a refrigerant is returned to a refrigerant circuit from a refrigerant amount control tank 8 that is installed in the bypass pipe 7/9. <IMAGE>
Patent PT-1436092-E (PT)
Title: Adhesive tape used as an aid when applying caulk or grout in ceramic tile corners
Inventor: LIAN FRANK
IPC: C09J7/20
Filed: 2002-09-13
Abstract: A caulking or grouting aid comprising two identical, double-sided adhesive strips 12 and 12' attached to a backing strip 14 such that adhesive strip 12 and 12' are parallel to one another and are spaced apart forming a uniform, intermediate channel. The backing strip is folded in half, such that the exposed edge of backing strip 14 can be inserted into the corner of a wall, then unfolded such that the front sides of the adhesive strips become adhered to the adjacent walls, forming a uniform channel into which caulk or grout can be applied.
Patent PT-1587801-E (PT)
Title: A process for preparing duloxetine and intermediates for use therein
Inventor: KANKAN RAJENDRA NARAYANRAO
IPC: A61K31/381
Filed: 2003-12-10
Abstract: A process for making (+)duloxetine or an acid addition salt thereof, comprising reacting intermediate compounds of formulae (I) and (II) so as to yield a compound of formula (III), or an acid addition salt thereof in the presence of a base and a phase transfer catalyst, where one of X and Y is hydroxy and the other is a leaving group, and subjecting a compound of formula (III), or an acid addition salt thereof, to further process steps so as to yield (+) duloxetine, or an acid addition salt thereof, substantially free of (-)duloxetine.
Patent PT-1636585-E (PT)
Title: Diaryl ureas with kinase inhibiting activity
Inventor: LYNCH MARK
IPC: A61K45/06
Filed: 2004-05-19
Abstract: The present invention provides methods for treating and/or preventing conditions and diseases in humans and other mammals that are associated with and/or mediated by signal transduction pathways comprising platelet-derived growth factor receptor (PDGFR) by administering diaryl ureas of Formula I. The present invention also provides devices and methods for treating, ameliorating, preventing, or modulating restenosis following angioplastic surgery or other invasive procedures that affect or injure the vascular system, and graft rejection following transplantation of a donor tissue into a host, where a stent or other omplantable device comprises an effective amount of diaryl ureas of Formula I.
Patent PT-1969036-E (PT)
Title: Biopolymer extraction from plant materials
Inventor: CORNISH KATRINA
IPC: B02C13/00
Filed: 2006-04-21
Abstract: Disclosed is a method and apparatus for the extraction of high molecular weight biopolymers from plants. Specifically, invention described herein relates to the commercial processing of plant material, including that from desert plants native to the southwestern United States and Mexico, such as the guayule plant (Parthenium argentatum), for the extraction of biopolymers, including natural rubbers. More specifically, the invention relates to laboratory to commercial scale extraction of high molecular weight biopolymers from plant materials including the chemical and mechanical processing of the plants and purification of the extracted biopolymer.
Patent PT-1946436-E (PT)
Title: Power converters
Inventor: STIESDAL HENRIK
IPC: H02M5/458
Filed: 2006-11-13
Abstract: The present invention provides a method of operating a wind turbine including a generator (4) that provides variable voltage at variable frequency and has a stator and a rotor. The wind turbine includes a turbine assembly (2) having at least one blade for rotating the rotor of the generator (4), and a power converter that interfaces the generator (4) to a supply network (NETWORK) operating at nominally fixed voltage and nominally fixed frequency. The power converter includes a generator bridge (10) electrically connected to the stator of the generator (4) and a network bridge (14). A dc link (12) is connected between the generator bridge (10) and the network bridge (14). A filter (16) having network terminals is connected between the network bridge (14) and the supply network. A first controller (18) is provided for controlling the operation of the semiconductor power switching devices of the generator bridge (14). Similarly, a second controller (46) is provided for controlling the operation of the semiconductor power switching devices of the network bridge (14). In response to a change in wind speed (e.g. an increasing or decreasing wind speed) the method comprises the steps of: (i) controlling the second active rectifier/inverter (14) to change the level of power exported out of the dc link (12) such that the dc link voltage changes from a desired level, and (ii) controlling the first active rectifier/inverter (10) to import sufficient current into the dc link (12) through the generator bridge (10) from the generator (4) to restore the dc link voltage to the desired level.
Patent PT-1999491-E (PT)
Title: Method for determining the instantaneous position of an acoustic section of a towed antenna
Inventor: STEINER HANS-JOACHIM
IPC: G01V1/38
Filed: 2007-02-16
Abstract: A method is specified for determining the instantaneous position of an acoustics section of a towed antenna (11) which is towed by a towing vehicle (10) in the water. In order to determine a sufficiently accurate position without additional hardware complexity and with no need for demanding computation power, the position of the acoustics section is fixed at at least one selected point (14) in the acoustics section, and the position (P<SUB>t2</SUB>) of the selected point (14) is estimated after the towing vehicle (10) has travelled over a defined distance (19), by means of a model from the positions (O<SUB>t1</SUB>, P<SUB>t1</SUB>) assumed by the towing vehicle (10) and the selected point (14) at the start of the distance travelled (19) and the position (O<SUB>t2</SUB>) assumed by the towing vehicle (10) at the end of the distance travelled (19) including the deployed length (L) of the towed antenna and the towing depth of the acoustics section.
Patent PT-2089425-E (PT)
Title: Anti-angiogenic compounds
Inventor: BRADSHAW CURT
IPC: A61K38/18
Filed: 2007-11-12
Abstract: The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis.
Patent PT-2149609-E (PT)
Title: Improved process for the production of daptomycin
Inventor: BERTETTI GIANLUCA
IPC: C12P21/04
Filed: 2008-08-01
Abstract: The present invention relates to an improved process for the production of Daptomycin by fermentation with Streptomyces roseosporus, in the presence of n-decanal or Cuphea oil as sources of the n-decanoyl side chain. These reagents allow to reduce toxicity effects on the bacteria and to avoid the use of solvents in the feeding solution.
Patent PT-2332582-E (PT)
Title: Ace2 activation for treatment of heart, lung and kidney disease and hypertension
Inventor: CRACKOWER MICHAEL A
IPC: C12N5/06
Filed: 2003-06-19
Abstract: The invention relates to an ACE2 genotyping kit comprising a detection agent for detecting the presence of an ACE2 polymorphism in a nucleic acid sample derived from an animal, preferably a human.
Patent PT-669977-E (PT)
Inventor: BACH FRITZ H
IPC: A61K35/12
Filed: 1993-10-29
Abstract: Endothelial cells which express a protein having I kappa B activity such that NF kappa B activation of the cells is substantially blocked may be prepared by altering the genetic material of the cells so that I kappa B activity is expressed continuously, immediately following endothelial cell activiting stimuli or on demand in response to a predetermined external stimulus e.g. by introducing heterologous I kappa B coding sequences or promoters into the cells. Organs and tissue comprising such endothelial cells are useful in transplantation e.g. xenotransplantation, as they are advantageously less susceptible to rejection.
Patent PT-662427-E (PT)
Inventor: WIEDMER ERNST
IPC: B65D41/04
Filed: 1994-12-14
Abstract: A plastic screw cap for initial, mechanised closure of a container has a thread (13) similar to that (1.7) of the container neck and projections (1.4, 1.5, 1.6) on the rounded edge formed by the cap inner wall (1.2) and the cover plate. The cap screw-on action ends suddenly when the container thread (1.7) contacts the projections. A claimed use for the cap is in the initial mechanised closure of glass or plastic, esp. PET bottles with screw threaded necks. The entire cap including projections, reinforcements is injection moulded in plastic.
Patent PT-730036-E (PT)
Inventor: ZENONI MAURIZIO
IPC: A61K31/43
Filed: 1996-02-05
Abstract: A process for producing penicillins and cephalosporins by reacting a beta -lactam nucleus with an amide. The reaction is catalyzed by a penicillin acylase enzyme and takes place in the presence of enzyme inhibitors.
Patent PT-902694-E (PT)
Inventor: BOTICH MICHAEL J
IPC: A61M5/24
Filed: 1996-08-20
Abstract: An injection device for administration of fluid medication is provided with a retraction mechanism for safety retracting the injection needle after administration of the injection. The device comprises a barrel for receiving a pre-filled medication cartridge containing a supply of fluid medication and sealed by a slidable plug. A plunger is positioned in the barrel. The plunger includes a rear portion for engaging and puncturing the plug, and for holding the plug at a stationary position as the cartridge is merged into the barrel to administer the injection. The player further includes a formal end for releasing the needle for the needle retraction mechanism when the cartridge has been urged into the barrel after the and of an injection stroke.
Patent PT-912565-E (PT)
Inventor: LINDSTROM KYLE J
IPC: C07D/
Filed: 1996-10-22
Abstract: A process for preparing 1H-imidazo[4,5-c]quinolin-4-amines is disclosed. The process involves reacting a 6H-imidazo[4,5-c]tetrazolo[1,5-a]quinoline with triphenylphosphine and hydrolyzing the product thereof.
Patent PT-996409-E (PT)
Inventor: WISNIEWSKI STEPHEN J
IPC: A61K8/66
Filed: 1997-06-25
Abstract: The present invention utilizes serine proteases and their ability to induce programmed cell death and apoptosis in the follicular papillae to affect changes in mammalian hair growth and hair pigmentation. Also described are compositions which have an agent with a portion of similar structure to a portion of the trypsin molecule, allowing said agent to induce programmed cell death and apoptosis in the same manner as trypsin.
Patent PT-996617-E (PT)
Inventor: THOM STEPHEN
IPC: C07D403/06
Filed: 1998-06-25
Abstract: PCT No. PCT/SE98/01240 Sec. 371 Date Sep. 30, 1998 Sec. 102(e) Date Sep. 30, 1998 PCT Filed Jun. 25, 1998 PCT Pub. No. WO99/02501 PCT Pub. Date Jan. 21, 1999The invention relates to new pharmaceutically active compounds which are P2-purinoceptor 7-transmembrane (TM) G-protein coupled receptor antagonists, compositions containing them and processes for their preparation.
Patent SG-9795-G (SG)
Title: Power-coupling device
Inventor: DESTRADE MICHEL
IPC: H01P5/12
Filed: 1995-01-21
Abstract: Power coupling device which can be used with metre and decimetre waves. In order to share out to n users (E1-En) in an equipotential and equiphase manner the energy coming from m equipotential and equiphase sources (J1-Jm), at the output of each source is connected up a 3dB, 90 DEG  hybrid circuit (H1-Hm) which distributes the power equally and with an aperiodic phase shift of 90 DEG  to two equipotential and equiphase distribution boxes (G1-G2) with m inputs and n outputs, exhibiting the same input/output phase shift. The two boxes are connected respectively to the two pathways of a pair of conjugate pathways of n 3dB, 90 DEG  hybrid circuits (F1-Fn); the recombined powers in these n circuits are delivered respectively to the n users (E1-En). Application in particular to power transmitters. <IMAGE>
Patent IE-840006-L (IE)
Title: Penem carboxylic esters
IPC: C07D499/883
Filed: 1984-01-04
Abstract: A method is provided for treating a warm-blooded animal having a susceptible bacterial infection which comprises administering orally to said animal a non-toxic, antibacterially effective amount of acetoxymethyl ester of (5R,6S)-2(5R,6S)-2-carbamoyloxymethyl-6-[1(R)-hydroxyethyl]-2-penem-3- carboxylic acid.
[US5051416A]
Patent IE-860075-L (IE)
Title: Antiviral agents
IPC: C07H3/06
Filed: 1986-01-10
Abstract: A second-step virus binding receptor is found in nature on the surface of animal and plant cells. This receptor is thought to be needed for virus penetration into target cells. The second-step receptor has been found to bind a wide variety of viruses belonging to a number of different families. The second-step receptor and natural or synthetic substances which correspond to or are analogous to the binding epitope of the second-step receptor in that they are able to bind to a site on the virus which recognizes the binding epitope of the natural second-step receptor, are therefore indicated for the diagnostic, prophylaxis or treatment of viral infections.
[WO8603971A1]
Patent IE-870131-L (IE)
Title: Hydroxyacetic acid heterocyclic derivatives
IPC: C07D311/96
Filed: 1987-01-20
Abstract: Racemic and chiral (2R,4R)-4-c-hydroxy-2-r-(substituted) chroman (and thiochroman)-4-acetic acids and their pharmaceutically acceptable salts useful in the treatment of diabetic complications, and intermediates therefor.
Patent IE-40676-L (IE)
Title: Dibenzo (thiepino or oxepino-) -pyrrole compounds
IPC: C07D491/044
Filed: 1975-02-21
Abstract: 1499727 2,3 - Dihydro - 1H - debenzo- [2,3; 6,7]thiepino- or oxepino-[4,5-c]-pyrroles CIBA-GEIGY AG 13 Feb 1975 [22 Feb 1974] 6150/75 Heading C2C Novel compounds I and salts thereof in which X is O or S, R is OH or alkanoyloxy and R 1 is C 1-7 alkyl or C 1-7 alkenyl are prepared by (1) reacting a compound II in which X 1 and X 2 are reactive esterified hydroxy groups with an amine R 1 NH 2 or (2) alkylating or alkenylating a compound IV compounds I (R = OH) are also prepared by hydrolysing a corresponding ether or ester derivative or by diazotization of a 5-amino group; compounds I (R = alkanoyloxy) are also prepared by acylating a compound I (R = OH); and a compound I obtained may be converted into the salts or a salt thereof converted to the corresponding free base. Compounds I have CNS-depressant and agitation-inhibiting activity and form with a carrier a pharmaceutical composition which may be administered orally or parenterally.
[GB1499727A]
Patent IE-840393-L (IE)
Title: Anti fungal di(azolyl) propanol derivatives
IPC: C07D249/08
Filed: 1984-02-20
Abstract: This invention relates to novel antifungal azole compound of the formula:  <IMAGE>  wherein X and Y are CH or N, R1 is optionally substituted phenyl or phenylalkyl, 1-6C alkyl or 3-8C cycloalkyl, R2 and R3 are hydrogen or 1-6C alkyl, and R4 and R5 are hydrogen, NH2, 1-6C alkyl, alkoxyalkyl, aminoalkyl, alkylaminoalkyl, dialkylamino or alkenyl wherein each alkyl, alkoxy or alkenyl part is of 1-6C, phenyl, phenyl-(1-6C)-alkyl, phenoxy-(1-6C)-alkyl or phenyl-(2-6C)-alkenyl in which the phenyl may be optionally substituted, or a heterocyclyl, (heterocyclyl)-(1-6C)-alkyl or (heterocyclyl)-(2-6C)-alkenyl in each of which the heterocyclyl ring may be optionally substituted, provided at least one of R2, R3, R4 and R5 is other than hydrogen, and the acid addition salts of those compounds which contain a basic nitrogen; together with processes for their manufacture; compositions containing them; and a method of combatting plant fungal diseases.
Patent IE-36314-L (IE)
Title: Tobacco flavourant.
IPC: A24B15/28
Filed: 1972-04-20
Abstract: 1349537 Microcapsules IMPERIAL TOBACCO GROUP Ltd 19 April 1972 [25 May 1971] 16850/71 Heading B8C [Also in Division A2] Microencapsulated menthol, used for flavouring cigarettes (see Division A2), is made by emulsifying a mixture of menthol dissolved in maize oil with an aqueous, acetic acid acidified, solution of gelatine at 40 C., mixing an aqueous gum acacia solution with the so formed emulsion, slowly diluting the mixture with water and then cooling it to 27 C. while stirring, and then hardening the resultant slurried microcapsules by the addition of glutaraldehyde. It was found that a pH of 4-2 for the mixture of the gum acacia with the emulsion was critical for subsequent successful encapsulation.
[GB1349537A]
Patent IE-900743-L (IE)
Title: £3-(C16-C18)-alkanesulphinyl- and¹-sulphonyl-2-methoxy-methylpropyl|-(2-trimethylammonioethyl)¹phosphates, processes for the preparation thereof and¹pharmaceutical compositions containing them
IPC: C07F9/10
Filed: 1990-03-02
Abstract: 3-(C16-C18)Alkanesulphinyl- and sulphonyl-2-methoxymethylpropyl (2-trimethylammonioethyl)phosphates, their pharmacologically acceptable salts, process for their preparation and medicaments having antitumour action containing these compounds.
Patent IE-39215-L (IE)
Title: Production of metal strip
IPC: B22F3/10
Filed: 1974-04-17
Abstract: Process comprises compacting powder to form green strip feeding the green strip to a sinter furnace, and supporting the strip by a gaseous cushion as it is transported through the furnace, the strip transport being controlled so that the tensile stress applied to the strip during its passage through the furnace is substantially zero.
[FR2227919A1]